70 related articles for article (PubMed ID: 26856369)
1. Continuous quantification of HER2 expression by microfluidic precision immunofluorescence estimates HER2 gene amplification in breast cancer.
Dupouy DG; Ciftlik AT; Fiche M; Heintze D; Bisig B; de Leval L; Gijs MA
Sci Rep; 2016 Feb; 6():20277. PubMed ID: 26856369
[TBL] [Abstract][Full Text] [Related]
2. MIM-CyCIF: masked imaging modeling for enhancing cyclic immunofluorescence (CyCIF) with panel reduction and imputation.
Sims Z; Mills GB; Chang YH
Commun Biol; 2024 Apr; 7(1):409. PubMed ID: 38570598
[TBL] [Abstract][Full Text] [Related]
3. MIM-CyCIF: Masked Imaging Modeling for Enhancing Cyclic Immunofluorescence (CyCIF) with Panel Reduction and Imputation.
Sims Z; Mills GB; Chang YH
bioRxiv; 2023 Aug; ():. PubMed ID: 37645765
[TBL] [Abstract][Full Text] [Related]
4. Fully automated sequential immunofluorescence (seqIF) for hyperplex spatial proteomics.
Rivest F; Eroglu D; Pelz B; Kowal J; Kehren A; Navikas V; Procopio MG; Bordignon P; Pérès E; Ammann M; Dorel E; Scalmazzi S; Bruno L; Ruegg M; Campargue G; Casqueiro G; Arn L; Fischer J; Brajkovic S; Joris P; Cassano M; Dupouy D
Sci Rep; 2023 Oct; 13(1):16994. PubMed ID: 37813886
[TBL] [Abstract][Full Text] [Related]
5. Automated multimodal fluorescence microscopy for hyperplex spatial-proteomics: Coupling microfluidic-based immunofluorescence to high resolution, high sensitivity, three-dimensional analysis of histological slides.
Furia L; Pelicci S; Perillo F; Bolognesi MM; Pelicci PG; Facciotti F; Cattoretti G; Faretta M
Front Oncol; 2022; 12():960734. PubMed ID: 36313693
[No Abstract] [Full Text] [Related]
6. A 3D mixing-based portable magnetic device for fully automatic immunofluorescence staining of γ-H2AX in UVC-irradiated CD4
Zhong R; Hou L; Zhao Y; Wang T; Wang S; Wang M; Xu D; Sun Y
RSC Adv; 2020 Aug; 10(49):29311-29319. PubMed ID: 35521108
[TBL] [Abstract][Full Text] [Related]
7. Identification of Key microRNAs and Genes in Infantile Hemangiomas.
Fu C; Yang K; Zou Y; Huo R
Front Genet; 2022; 13():766561. PubMed ID: 35360837
[TBL] [Abstract][Full Text] [Related]
8. Spatial protein heterogeneity analysis in frozen tissues to evaluate tumor heterogeneity.
Fomitcheva-Khartchenko A; Rapsomaniki MA; Sobottka B; Schraml P; Kaigala GV
PLoS One; 2021; 16(11):e0259332. PubMed ID: 34797831
[TBL] [Abstract][Full Text] [Related]
9. Rapid micro-immunohistochemistry.
Lovchik RD; Taylor D; Kaigala G
Microsyst Nanoeng; 2020; 6():94. PubMed ID: 34567704
[TBL] [Abstract][Full Text] [Related]
10. Recombinant immunotoxins development for HER2-based targeted cancer therapies.
Mahmoudi R; Dianat-Moghadam H; Poorebrahim M; Siapoush S; Poortahmasebi V; Salahlou R; Rahmati M
Cancer Cell Int; 2021 Sep; 21(1):470. PubMed ID: 34488747
[TBL] [Abstract][Full Text] [Related]
11. Breast tumor-on-chip models: From disease modeling to personalized drug screening.
Subia B; Dahiya UR; Mishra S; Ayache J; Casquillas GV; Caballero D; Reis RL; Kundu SC
J Control Release; 2021 Mar; 331():103-120. PubMed ID: 33417986
[TBL] [Abstract][Full Text] [Related]
12. Microfluidics-assisted multiplexed biomarker detection for in situ mapping of immune cells in tumor sections.
Migliozzi D; Pelz B; Dupouy DG; Leblond AL; Soltermann A; Gijs MAM
Microsyst Nanoeng; 2019; 5():59. PubMed ID: 31700674
[TBL] [Abstract][Full Text] [Related]
13. Microfluidic-based immunohistochemistry for breast cancer diagnosis: a comparative clinical study.
Aimi F; Procopio MG; Alvarez Flores MT; Brouland JP; Piazzon N; Brajkovic S; Dupouy DG; Gijs M; de Leval L
Virchows Arch; 2019 Sep; 475(3):313-323. PubMed ID: 31267199
[TBL] [Abstract][Full Text] [Related]
14. Ultra-fast and automated immunohistofluorescent multistaining using a microfluidic tissue processor.
Cappi G; Dupouy DG; Comino MA; Ciftlik AT
Sci Rep; 2019 Mar; 9(1):4489. PubMed ID: 30872751
[TBL] [Abstract][Full Text] [Related]
15. A microfluidic platform towards automated multiplexed in situ sequencing.
Maïno N; Hauling T; Cappi G; Madaboosi N; Dupouy DG; Nilsson M
Sci Rep; 2019 Mar; 9(1):3542. PubMed ID: 30837556
[TBL] [Abstract][Full Text] [Related]
16. High-content, cell-by-cell assessment of HER2 overexpression and amplification: a tool for intratumoral heterogeneity detection in breast cancer.
Nguyen HT; Migliozzi D; Bisig B; de Leval L; Gijs MAM
Lab Invest; 2019 May; 99(5):722-732. PubMed ID: 30659272
[TBL] [Abstract][Full Text] [Related]
17. Combining fluorescence-based image segmentation and automated microfluidics for ultrafast cell-by-cell assessment of biomarkers for HER2-type breast carcinoma.
Migliozzi D; Nguyen HT; Gijs MAM
J Biomed Opt; 2018 Nov; 24(2):1-8. PubMed ID: 30484294
[TBL] [Abstract][Full Text] [Related]
18. Microfluidics-based immunofluorescence for fast staining of ALK in lung adenocarcinoma.
Brajkovic S; Pelz B; Procopio MG; Leblond AL; Repond G; Schaub-Clerigué A; Dupouy DG; Soltermann A
Diagn Pathol; 2018 Oct; 13(1):79. PubMed ID: 30326973
[TBL] [Abstract][Full Text] [Related]
19. Electrophoretic cytopathology resolves ERBB2 forms with single-cell resolution.
Kang CC; Ward TM; Bockhorn J; Schiffman C; Huang H; Pegram MD; Herr AE
NPJ Precis Oncol; 2018; 2():10. PubMed ID: 29872719
[TBL] [Abstract][Full Text] [Related]
20. Microfluidics for rapid cytokeratin immunohistochemical staining in frozen sections.
Brajkovic S; Dupouy DG; de Leval L; Gijs MA
Lab Invest; 2017 Aug; 97(8):983-991. PubMed ID: 28553936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
